Legal status in Bahamas

2-FDCK

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for 2-FDCK, for fluorodeschloroketamine and for the chemical name: zero hits in every one, including the 2024 draft Order, which does name ketamine. The nearest entries read and rejected are the four arylcyclohexylamines that the Order does name, «PHENCYCLIDINE», «ETICYCLIDINE», «ROLICYCLIDINE» and «TENOCYCLIDINE». None of them is a fluorinated arylcyclohexanone, and the parent compound ketamine is itself absent from the operative Order, so there is no listed entry for this one to be an analogue of.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

2-FDCK in Bahamas, full detail →

25I-NBOMe

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for 25I-NBOMe, for NBOMe and for the methoxybenzyl chemical fragment: zero hits in the Act and zero in the operative 1994 Order. The string NBOMe occurs six times, and 25I once, only in the 2024 draft Order. The nearest entry read and rejected is «BROLAMFETAMINE», trivial name DOB, chemical name «(+-)-4-bromo-2,5-dimethoxy-alpha methylphenethylamine» in Substances in Schedule I of the Psychotropic Convention list. That is an alpha methyl phenethylamine with a bromine, not an iodinated N benzyl phenethylamine, and the psychotropic schedules in this Order carry no isomer or analogue clause.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

25I-NBOMe in Bahamas, full detail →

2C-B

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for 2C-B, for bromo-2,5-dimethoxyphenethylamine and for the trivial names: zero hits in the Act and zero in the operative 1994 Order. The string 2C-B occurs twice, only in the 2024 draft Order. The nearest entry read and rejected is «BROLAMFETAMINE» against the trivial name DOB, chemical name «(+-)-4-bromo-2,5-dimethoxy-alpha methylphenethylamine», in Substances in Schedule I of the Psychotropic Convention list. It carries the same bromine and the same two methoxy groups but it has the alpha methyl group that makes it an amphetamine; this substance has no alpha methyl group and is a phenethylamine. They are two different drugs and only the first is listed.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

2C-B in Bahamas, full detail →

2C-E

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for 2C-E and for ethyl-2,5-dimethoxyphenethylamine: zero hits in every one, including the 2024 draft Order, which names 2C-B and 2C-I but not this one. The nearest entry read and rejected is «DOET», chemical name «(+-)-4-ethyl-2,5-dimethoxy-alpha-phenethylamine» in Substances in Schedule I of the Psychotropic Convention list. DOET carries the same ethyl group in the same position, and differs by the alpha methyl that makes it an amphetamine rather than a phenethylamine.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

2C-E in Bahamas, full detail →

2C-I

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for 2C-I and for iodo-2,5-dimethoxyphenethylamine: zero hits in the Act and zero in the operative 1994 Order. The string 2C-I occurs once, only in the 2024 draft Order. The nearest entries read and rejected are «BROLAMFETAMINE», the brominated amphetamine DOB, and «DMA», chemical name «(+-)-2,5-dimethoxy-alpha-methylphenethylamine», which is the unsubstituted parent of that series. No iodinated phenethylamine is named anywhere in the operative Order.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

2C-I in Bahamas, full detail →

2C-T-7

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for 2C-T-7 and for the propylthio dimethoxyphenethylamine chemical name: zero hits in every one, including the 2024 draft Order. The nearest entries read and rejected are the thiophene bearing narcotics «Diethylthiambutene» and «Dimethylthiambutene» in the List of Drugs Included in Schedule I, which share only the sulphur atom and are opioids of a wholly different class. No sulphur substituted phenethylamine appears in the psychotropic schedules.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

2C-T-7 in Bahamas, full detail →

3-MMC

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for 3-MMC and for methylmethcathinone: zero hits in the Act and zero in the operative 1994 Order. Methylmethcathinone occurs once, only in the 2024 draft Order. The nearest entry read and rejected is «METHCATHINONE», other names «ephedrone» and «methylcathinone», chemical name «2-Methylamino)-1-phenylpropan-1-one» in Substances in Schedule I of the Psychotropic Convention list. That is the unsubstituted ring compound; this one carries a methyl group on the ring, and the Order lists cathinones one molecule at a time with no class rule to carry the substitution across.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

3-MMC in Bahamas, full detail →

4-AcO-DMT

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for 4-AcO-DMT, for acetoxy-N,N-dimethyltryptamine and for psilacetin: zero hits in every one. The string acetoxy returns four hits in the 1994 Order, all of them inside opioid chemical names such as «Alphacetylmethadol (alpha-3-acetoxy-6-dimethylamino-4,4-diphenylheptane)» and none of them a tryptamine. The nearest entries read and rejected are «PSILOCYBINE», the 4 phosphoryloxy ester, and «psilocine, psilotsin», the 4 hydroxy compound, both in Substances in Schedule I of the Psychotropic Convention list. This substance is the 4 acetoxy ester of the same alcohol and is a third, unnamed, ester; the psychotropic schedules carry no ester clause, although the narcotic Schedule I does.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

4-AcO-DMT in Bahamas, full detail →

4-HO-MET

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for 4-HO-MET, for metocin and for hydroxy-N-methyl-N-ethyltryptamine: zero hits in every one, including the 2024 draft Order. The nearest entries read and rejected are «psilocine, psilotsin», chemical name «3-[2-(dimethylamino)ethyl]indol-4-ol», which is the 4 hydroxy dimethyl compound, and «DET», chemical name «3-[2-(diethylamino)ethyl]indole», which is the diethyl compound without the hydroxyl. This substance is the mixed methyl ethyl 4 hydroxy compound and is neither of them.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

4-HO-MET in Bahamas, full detail →

5-MeO-DMT (Bufo / Toad)

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for 5-MeO-DMT and for methoxy-N,N-dimethyltryptamine: zero hits in every one, including the 2024 draft Order. The nearest entry read and rejected is «DMT», chemical name «3-[2-(dimethylamino)ethyl]indole» in Substances in Schedule I of the Psychotropic Convention list. This substance is that molecule with a methoxy group at the 5 position of the indole ring. The Order's indole entries name each ring substitution pattern separately, «DMT», «DET», «psilocine» at the 4 position and «ETRYPTAMINE», and none of them carries a 5 methoxy group.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

5-MeO-DMT (Bufo / Toad) in Bahamas, full detail →

6-APB

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for 6-APB, for benzofuran and for benzofuranylpropanamine: zero hits in every one, including the 2024 draft Order. The nearest entry read and rejected is «TENAMFETAMINE», trivial name MDA, chemical name «alpha-methyl-3,4-(methylenedioxy)phenethylamine» in Substances in Schedule I of the Psychotropic Convention list. This substance replaces that compound's methylenedioxy ring with a benzofuran ring and is a different molecule; no benzofuran appears anywhere in either operative instrument.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

6-APB in Bahamas, full detail →

7-Hydroxymitragynine (7-OH)

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for 7-hydroxymitragynine, for mitragynine and for Mitragyna: zero hits in every one, including the 2024 draft Order. There is no nearest entry to reject, because no indole alkaloid of this family is named anywhere in the two operative instruments. The closest listed indoles are the simple tryptamines «DMT», «DET» and «ETRYPTAMINE», which share only the indole nucleus.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

7-Hydroxymitragynine (7-OH) in Bahamas, full detail →

Adderall

Legal status: Controlled through its constituents, not under its brand name, which appears nowhere in either instrument. The mixed salts are dextroamphetamine and racemic amphetamine, and the 1994 Order prints both: «AMFETAMINE», other name «amphetamine», and «DEXAMFETAMINE», other name «dexamphetamine», chemical name «(+)-alpha-methylphenethylamine», both in Substances in Schedule II of the Psychotropic Convention list. Section 11(1)(j) of the Act reaches amphetamines directly. A case insensitive search returned dexamfetamine once and dexamphetamine once in the 1994 Order and zero occurrences of the brand name in all three held instruments.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27. A visitor holding a lawful foreign prescription is not within section 24, which authorises a qualified person and not a patient.
Documentation: The two active ingredients are what a charge would name; the brand is not a legal category in The Bahamas. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Adderall in Bahamas, full detail →

Alcohol

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for alcohol and for ethanol. The single hit for alcohol and the two for ethanol in the 1994 Order are fragments of chemical names, «(+)-(R)-alpha-[(R)-1-aminoethyl]benzyl alcohol» against the entry «CATHINE» and «piperazine-ethanol» against the entry «ZIPEROL». Neither is an entry for ethyl alcohol, and the Act does not mention it at all. There is no nearest entry to reject. Beverage alcohol is not a dangerous drug under Chapter 228 and is dealt with by excise and licensing law that was not read for this cell.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Alcohol in Bahamas, full detail →

Amanita muscaria

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for Amanita, for muscaria, for muscimol and for ibotenic: zero hits in every one, including the 2024 draft Order. There is no nearest entry to reject, because no isoxazole is named anywhere in either instrument. The fungal alkaloids the Order does reach are the tryptamines «PSILOCYBINE» and «psilocine, psilotsin», which are chemically unrelated to this mushroom's constituents.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Amanita muscaria in Bahamas, full detail →

Amphetamine

Legal status: Controlled by two independent routes. Section 11(1)(j) of the Dangerous Drugs Act, Chapter 228, applies Part IV to «amphetamines(beta-aminopropylbenzene and beta-aminoisopropylbenzene)», the 1920s chemical naming rather than the modern one, and it is the Act's only mention of the word, counted once. Independently the 1994 Order prints «AMFETAMINE» against the other non proprietary name «amphetamine» and the chemical name «(+-)-alpha-methylphenethylamine» in Substances in Schedule II of the Psychotropic Convention list, with «DEXAMFETAMINE», «LEVAMFETAMINE» and «METAMFETAMINE RACEMATE» beside it.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: The Order spells the entry with an f, in the international non proprietary form, and the Act spells it with a ph. Both are the same drug and either spelling will be met on a charge. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Amphetamine in Bahamas, full detail →

Amyl Nitrite

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for nitrite, for amyl and for isobutyl: zero hits in every one, including the 2024 draft Order. There is no nearest entry to reject. No alkyl nitrite, and indeed no volatile inhalant of any kind, is named in Chapter 228 or in the 1994 Order.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Amyl Nitrite in Bahamas, full detail →

Ayahuasca

Legal status: Controlled through one of its constituents and not by its own name. Searched case insensitively across the three held instruments: ayahuasca returns zero hits, Banisteriopsis returns zero, and harmine returns zero. The 1994 Application Order prints «DMT», chemical name «3-[2-(dimethylamino)ethyl]indole», in Substances in Schedule I of the Psychotropic Convention list, and the brew's active tryptamine is that substance. The monoamine oxidase inhibiting harmala alkaloids that make it orally active are not named anywhere in either instrument.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27. No religious or sacramental exemption appears in Chapter 228 or in the 1994 Order.
Documentation: A charge would rest on the DMT content, so the brew is treated as a preparation of a named substance. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Ayahuasca in Bahamas, full detail →

Barbiturates

Legal status: Controlled as individually named molecules spread across three tiers, never as a class. The 1994 Application Order prints «SECOBARBITAL» in Substances in Schedule II of the Psychotropic Convention list; «AMOBARBITAL», «BUTALBITAL», «CYCLOBARBITAL» and «PENTOBARBITAL» in Schedule III; and «ALLOBARBITAL», «BARBITAL», «butobarbital», «METHYLPHENOBARBITAL», «PHENOBARBITAL», «SECBUTABARBITAL» and «VINYLBITAL» in Schedule IV. The string barbituric appears twelve times in that Order, always inside a chemical name such as «5,5-diethylbarbituric acid», and never as a category heading. Counted: zero barbiturate entries in the Act.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: A barbiturate outside those twelve names is outside the Order, and the three tier spread makes no difference to the Bahamian penalty, which is set by the Act and not by the tier. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Barbiturates in Bahamas, full detail →

Benzodiazepines

Legal status: Controlled as a set of individually named molecules, never as a class. The 1994 Application Order names «FLUNITRAZEPAM» in Substances in Schedule III of the Psychotropic Convention list and roughly two dozen further benzodiazepines in Schedule IV of that list, including «ALPRAZOLAM», «BROMAZEPAM», «CAMAZEPAM», «CHLORDIAZEPOXIDE», «CLOBAZAM», «CLONAZEPAM», «CLORAZEPATE», «CLOTIAZEPAM», «CLOXAZOLAM», «DELORAZEPAM», «DIAZEPAM», «ESTAZOLAM», «ETHYL LOFLAZEPATE», «FLUDIAZEPAM», «FLURAZEPAM», «HALAZEPAM», «HALOXAZOLAM», «KETAZOLAM», «LOPRAZOLAM», «LORAZEPAM», «LORMETAZEPAM», «MEDAZEPAM», «MIDAZOLAM», «NIMETAZEPAM», «NITRAZEPAM», «NORDAZEPAM», «OXAZEPAM», «OXAZOLAM», «PINAZEPAM», «PRAZEPAM», «TEMAZEPAM», «TETRAZEPAM» and «TRIAZOLAM». The string benzodiazepin appears thirty three times in that Order and never once as a category. A benzodiazepine not on the list is outside it.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: Of the six corpus members in this class, five are named in the Order and etizolam is not, which is the practical consequence of listing by molecule. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Benzodiazepines in Bahamas, full detail →

Buprenorphine

Legal status: Controlled. The 1994 Application Order prints «BUPRENORPHINE» in Substances in Schedule III of the Psychotropic Convention list, with the chemical name «21-cyclopropyl-7-alpha[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine» and a footnote recording that it was included by decision of the Commission on Narcotic Drugs on 17 February 1989 and became fully effective on 18 September 1989. Measured: buprenorphine occurs once in the 1994 Order and zero times in the Act.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: It sits in the psychotropic list rather than the narcotic list, although it is an opioid; the Bahamian Act attaches the same Part IV consequences either way. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Buprenorphine in Bahamas, full detail →

Caffeine

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for caffeine: zero hits in every one, including the 2024 draft Order. The nearest entry read and rejected is «FENETHYLLINE», chemical name «7-[2-[(alpha-methylphenethyl)amino] ethyl]theophylline» in Substances in Schedule II of the Psychotropic Convention list. That is a xanthine joined to an amphetamine, and it is listed for the amphetamine half; the xanthine itself is not controlled.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Caffeine in Bahamas, full detail →

Cannabis / THC

Legal status: Controlled under the Dangerous Drugs Act, Chapter 228, which reaches it by the words «Indian hemp» rather than by the word cannabis. Section 6 applies Part II to «raw opium, coca leaves, Indian hemp and resins obtained from Indian hemp and all preparations of which such resins form a base», and section 2 defines «Indian hemp» as «all parts of any plant of the genus cannabis whether growing or not from which the resin has not been extracted; the resin extracted from any part of such plant; and every compound, manufacture, salt derivative, mixture or preparation of such plant or resin». Section 11(1)(b) applies Part IV to «any extract or tincture of Indian hemp». Searched case insensitively across all three held instruments: the operative 1994 Application Order prints the word cannabis nowhere at all, count zero, because the Act already names the plant; the word appears twice in the Act and twice in the 2024 draft Order, which is not law.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed. Section 22(8)(a) substitutes life imprisonment for the section 22 maxima where the quantity charged exceeds ten pounds of Indian hemp. Cultivation is charged separately: section 29(1)(e) makes it an offence to grow or cultivate in any part of The Bahamas «Indian hemp (any plant of the genus cannabis)», carrying the section 29(2) penalties.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27. No medicinal cannabis scheme appears in Chapter 228 or in the 1994 Order.
Documentation: A reported 2023 amendment removing the words Indian hemp from the Act, and a Cannabis Bill 2024, were not held or read in this pass and nothing here rests on either. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Cannabis / THC in Bahamas, full detail →

Cathinone

Legal status: Controlled, and its N methyl homologue is separately named. The 1994 Application Order prints «CATHINONE» with the chemical name «(-)-(S)-2-aminopropiophenone» in Substances in Schedule I of the Psychotropic Convention list, and «METHCATHINONE» against the other names «ephedrone» and «methylcathinone» in the same Schedule. A third related entry, «CATHINE», other name «(+)-norpseudoephedrine», sits in Schedule III of that list. Counted: cathinone three times in the 1994 Order and zero times in the Act.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: Three separate entries and no class clause, so a substituted cathinone that is not one of the three is outside the Order. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Cathinone in Bahamas, full detail →

Clonazepam

Legal status: Controlled. The 1994 Application Order prints «CLONAZEPAM» with the chemical name «5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one» in Substances in Schedule IV of the Psychotropic Convention list, between «CLOBAZAM» and «CLORAZEPATE». Counted: clonazepam once in the 1994 Order and zero times in the Act. The nitro substituted relatives «NIMETAZEPAM», «NITRAZEPAM» and «FLUNITRAZEPAM» are each named separately, the last of them in Schedule III.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: Four nitrobenzodiazepines are individually listed and none of them is reached by a class rule, because the psychotropic schedules in this Order carry no extension clause. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Clonazepam in Bahamas, full detail →

Cocaine

Legal status: Controlled. Section 11(1)(d) of the Dangerous Drugs Act, Chapter 228, applies Part IV to «cocaine (including synthetic cocaine) and ecgonine and their respective salts, and the esters of ecgonine and their respective salts», and section 6 applies Part II to «coca leaves», defined in section 2 as the leaves of any plant of the genus erythroxylaecae from which cocaine can be extracted. Section 11(1)(e) reaches any preparation containing not less than one fifth per cent of cocaine or of ecgonine. The word cocaine appears seventeen times in the Act on a case insensitive search, fifteen of them in lower case, and four times in the 1994 Order, where it is not a schedule entry but a concentration rule at Schedule III paragraph 4 exempting preparations containing not more than 0.1 per cent of cocaine calculated as cocaine base.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed. Section 22(8)(b) substitutes life imprisonment for the section 22 maxima where the quantity charged exceeds two pounds of cocaine.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: Section 12(1) additionally forbids trading in or manufacturing for trade any product obtained from the ecgonine alkaloids of the coca leaf that was not in medical or scientific use on 13 August 1975. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Cocaine in Bahamas, full detail →

Codeine

Legal status: Controlled, but by an unusual route, because the Act expressly takes it out of one paragraph and the Order then puts it back. Section 11(1)(h) of the Dangerous Drugs Act, Chapter 228, applies Part IV to «thebaine and its salts, and (with the exception of methylmorphine, commonly known as codeine, and ethylmorphine, commonly known as dionin, and their respective salts) benzylmorphine and the other esters of morphine». Section 12(4) then allows the Minister to apply Part IV to codeine and ethylmorphine by Order, and the 1994 Application Order does so: it prints «Codeine (3-methylmorphine)» in the List of Drugs Included in Schedule II. The word codeine occurs twice in the Act and twelve times in the 1994 Order.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: Schedule III paragraph 1 of the 1994 Order lists preparations of codeine compounded with other ingredients at not more than 100 milligrams per dosage unit and a concentration of not more than 2.5 per cent in undivided preparations, which is the low dose combination route. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Codeine in Bahamas, full detail →

Crack Cocaine

Legal status: Controlled, as cocaine. Chapter 228 nowhere prints the word crack and draws no distinction between cocaine base and cocaine salt: section 11(1)(d) applies Part IV to «cocaine (including synthetic cocaine) and ecgonine and their respective salts», which takes the free base and the hydrochloride together. The only place the Act separates a base from a salt is section 11(2)(c), a calculation rule for morphine. The only place the instruments use the phrase «cocaine base» is Schedule III paragraph 4 of the 1994 Order, a de minimis exemption for preparations at or under 0.1 per cent, which is the opposite of a smokable rock.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed. Section 22(8)(b) substitutes life imprisonment for the section 22 maxima where the quantity charged exceeds two pounds of cocaine. The two pound threshold is a weight of the drug charged and is not adjusted for the form it is in.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: The section 22(3) presumption of intent to supply, triggered by two or more packets, is the provision most likely to be met by the way this form is carried. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Crack Cocaine in Bahamas, full detail →

Delta-8-THC

Legal status: Controlled, by chemical name rather than by the label delta 8. Substances in Schedule I of the Psychotropic Convention list in the 1994 Application Order prints the heading «tetrahydrocannabinol, the following isomers and their stereochemical variants» and then six chemical names with no trivial names at all. One of the six is «(6aR,10aR)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol», which is delta 8 tetrahydrocannabinol; the identification is made here from the saturation pattern in that name and the string delta-8 occurs zero times in the operative instruments, appearing once only in the 2024 draft Order. Delta 9 is dealt with separately, in Schedule II of the same list as «delta-9-tetrahydrocannabinol and its stereochemical variants».
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: If the material is derived from the cannabis plant it is independently within the section 2 definition of Indian hemp, which reaches every preparation of that plant or its resin, so the isomer question only matters for synthetic material. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Delta-8-THC in Bahamas, full detail →

Diazepam

Legal status: Controlled. The 1994 Application Order prints «DIAZEPAM» with the chemical name «7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one» in Substances in Schedule IV of the Psychotropic Convention list, between «DELORAZEPAM» and «ESTAZOLAM». Counted: diazepam twice in the 1994 Order and zero times in the Act. Its active metabolites are separately listed in the same Schedule as «NORDAZEPAM», «OXAZEPAM» and «TEMAZEPAM».
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: Because the metabolites are named in their own right, a preparation is not brought in or taken out of the Order by what the body does to it. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Diazepam in Bahamas, full detail →

DMT

Legal status: Controlled. The 1994 Application Order prints «DMT» as an other non proprietary or trivial name against the chemical name «3-[2-(dimethylamino)ethyl]indole» in Substances in Schedule I of the Psychotropic Convention list; the international non proprietary name column for that row is blank in the printed table. The neighbouring entry «DET», chemical name «3-[2-(diethylamino)ethyl]indole», is the diethyl homologue and a separate substance. Counted: DMT once in the 1994 Order and zero times in the Act.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: The Psychotropic Convention schedules in this Order carry no general isomer, ester or salt clause, unlike the narcotic Schedules I and II, so an entry there reaches only what it names. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

DMT in Bahamas, full detail →

DOM

Legal status: Controlled, under its two trivial names. Substances in Schedule I of the Psychotropic Convention list in the 1994 Application Order prints «STP, DOM» in the other non proprietary or trivial names column against the chemical name «2,5-dimethoxy-alpha,4-dimethylphenethylamine»; the international non proprietary name column for that row is blank in the printed table. Counted: DOM once and STP once in the 1994 Order and zero of either in the Act. Neighbouring entries «DMA», «DOET», «MMDA» and «TMA» are separate substituted amphetamines, each named in its own right.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: The row is one of several in this table where the left hand column is blank because the substance has no international non proprietary name. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

DOM in Bahamas, full detail →

DXM

Legal status: Not controlled, and uniquely among the rows here it is excluded in terms. The 1994 Application Order's List of Drugs Included in Schedule I carries a footnote reading «Dextromethorphan ((+)-3-methoxy-N-methylmorphinan) and dextrorphan ((+)-3-hydroxy-N-methylmorphinan) are isomers specifically excluded from this Schedule». The point of the exclusion is that the mirror image compounds are listed: «Levomethorphan», «Racemethorphan», «Levorphanol», «Norlevorphenol» and «Racemorphan» all appear as Schedule I entries. So this is an express carve out and not a gap, and it stands as those schedules stand after S.I. 50 of 1996.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not. The exclusion is from the Schedule itself, so the drug is not one to which Part IV applies and no quantity of it engages section 22.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act. The exclusion says nothing about over the counter sale, which is a medicines question and not a drugs Act one.
Documentation: This is the only express exclusion of a named substance found anywhere in the two operative instruments. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

DXM in Bahamas, full detail →

Ephedrine

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for ephedrine and for pseudoephedrine. The single hit in the 1994 Order is not an entry for ephedrine: it is the chemical name «(+)-(R)-alpha-[(R)-1-aminoethyl]benzyl alcohol» printed against the entry «CATHINE», whose other non proprietary name is «(+)-norpseudoephedrine». The Act does not mention it. So the nearest entry read and rejected is «CATHINE» itself, in Substances in Schedule III of the Psychotropic Convention list. Norpseudoephedrine is a demethylated relative and a different substance. Chapter 228 contains no precursor control chapter at all, which is where a listing for this substance would normally sit.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Ephedrine in Bahamas, full detail →

Etizolam

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for etizolam: zero hits in the Act and zero in the operative 1994 Order. It occurs once, only in the 2024 draft Order. The nearest entry read and rejected is «CLOTIAZEPAM», chemical name «5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno[2,3-e]-1,4-diazepin-2-one» in Substances in Schedule IV of the Psychotropic Convention list. Clotiazepam is a thienodiazepine and this substance is a thienotriazolodiazepine, differing by the fused triazole ring. Of the six benzodiazepine family members in this corpus, it is the only one the Order does not name.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Etizolam in Bahamas, full detail →

Fentanyl

Legal status: Controlled. The 1994 Application Order prints «Fentanyl (1-phenethyl-4-N-propionylanilinopiperidine)» in the List of Drugs Included in Schedule I, together with «Alfentanil», «Sufentanil», «Thiofentanyl» and «Para-fluorofentanyl». Six fentanyl analogues are additionally repeated in the List of Drugs Included in Schedule IV, which in the 1961 Convention scheme is the tightest control: «Acetyl-alpha-methylfentanyl», «Alpha-methylfentanyl», «Alpha-methylthiofentanyl», «Beta-hydroxyfentanyl», «Beta-hydroxy-3-methylfentanyl», «3-methylfentanyl», «3-methylthiofentanyl» and «Thiofentanyl». A case insensitive count returns eighteen fentanyl strings in the 1994 Order and none in the Act.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: Schedule I of the 1994 Order closes with a general clause extending it to the isomers, the esters and ethers, and the salts of the drugs in that Schedule, so a salt of fentanyl is within it without being separately named. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Fentanyl in Bahamas, full detail →

Gabapentin

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for gabapentin: zero hits in the Act and zero in the operative 1994 Order. It occurs once, only in the 2024 draft Order, where it is grouped with pregabalin. There is no nearest entry to reject, because no gabapentinoid is named anywhere in either operative instrument. The 2024 draft would introduce the class for the first time, and it is not law.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Gabapentin in Bahamas, full detail →

GBL

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for GBL, for butyrolactone and for butanediol: zero hits in every one, including the 2024 draft Order, which does name the parent compound. There is no nearest entry to reject in the operative instruments, since the substance this one converts into is itself absent from them. No lactone and no precursor of any kind is named in Chapter 228 or in the 1994 Order.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

GBL in Bahamas, full detail →

GHB

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for GHB, for hydroxybutyric and for oxybate: zero hits in the Act and zero in the operative 1994 Order. Hydroxybutyric and GHB occur once each, only in the 2024 draft Order. There is no nearest entry to reject. The 1994 Order predates the 2001 addition of this substance to the Psychotropic Convention schedules, which is the ordinary reason a psychotropic substance is missing from it, and no Bahamian Order has been read that closes the gap.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

GHB in Bahamas, full detail →

Heroin

Legal status: Controlled, and the Act names it in the older British drafting form. Section 11(1)(c) applies Part IV to «morphine and its salts and diacetyl-morphine (commonly known as diamorphine or heroin) and the other esters of morphine and their respective salts», and section 11(1)(f) reaches «any preparation, admixture, extract or other substance containing any proportion of diacetyl-morphine». Searched case insensitively: heroin appears twice in the Act and zero times in the operative 1994 Order, which carries no entry for it because the Act had already named it; the two hits in the 2024 draft Order are not law.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed. Section 22(8)(c) substitutes life imprisonment for the section 22 maxima where the quantity charged exceeds twenty grams of opium, morphine or its salts including diacetylmorphine.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: The twenty gram figure in section 22(8)(c) is the lowest quantity threshold in the Act and is far below the two pound cocaine figure and the ten pound Indian hemp figure. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Heroin in Bahamas, full detail →

Hydrocodone

Legal status: Controlled, under the name «dihydrocodeinone». Section 11(1)(g) of the Dangerous Drugs Act, Chapter 228, applies Part IV to «dihydrohydroxycodeinone, dihydrocodeinone, dihydromorphinone, acetyldihydrocodeinone», and dihydrocodeinone is hydrocodone. The word hydrocodone occurs zero times in the Act and zero times in the 1994 Order. Two nearest entries were read and rejected: «Codoxime (dihydrocodeinone-6-carboxymethyloxime)» in the 1994 Order's narcotic Schedule I is an oxime derivative and a different substance, and «Dihydrocodeine» in that Order's narcotic Schedule II is a different substance again.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: The three names dihydrocodeinone, dihydrocodeine and codoxime sit close together in these instruments and are three separate drugs. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Hydrocodone in Bahamas, full detail →

Ketamine

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for ketamine: zero hits in the Act and zero in the operative 1994 Order. It occurs three times, only in the 2024 draft Order. The nearest entries read and rejected are the four arylcyclohexylamines the Order does name: «PHENCYCLIDINE», other name PCP; «ETICYCLIDINE», other name PCE; «ROLICYCLIDINE», other names PHP and PCPY; and «TENOCYCLIDINE», other name TCP. All four are cyclohexylamines; this substance is a cyclohexanone with a chlorinated aryl ring, and the psychotropic schedules in this Order carry no analogue clause that would carry the four across to it.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Ketamine in Bahamas, full detail →

Khat

Legal status: Controlled through its alkaloids rather than as a plant, and the plant itself is named nowhere. Searched case insensitively across all three held instruments: khat returns zero hits, qat returns zero, Catha returns zero and edulis returns zero. What the 1994 Application Order names are two constituents: «CATHINONE» in Substances in Schedule I of the Psychotropic Convention list and «CATHINE», other name «(+)-norpseudoephedrine», in Schedule III. So fresh leaf containing cathinone is a preparation of a listed substance as those schedules stand after S.I. 50 of 1996, while the plant as such is named nowhere.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: The cathinone content of the leaf falls away as it dries, which is a question of fact on any given consignment and not something the instruments address. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Khat in Bahamas, full detail →

Kratom

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for kratom, for Mitragyna and for speciosa: zero hits in every one, including the 2024 draft Order. There is no nearest entry to reject. The leaf is not named, its alkaloids mitragynine and 7-hydroxymitragynine are not named, and the only plants Chapter 228 names as plants are the opium poppy, the coca plant and Indian hemp, at section 6 and section 29(1)(e).
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Kratom in Bahamas, full detail →

Lorazepam

Legal status: Controlled. The 1994 Application Order prints «LORAZEPAM» with the chemical name «7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one» in Substances in Schedule IV of the Psychotropic Convention list, immediately above «LORMETAZEPAM», which differs by a single methyl group and is a separate entry. Counted: lorazepam twice in the 1994 Order and zero times in the Act.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: The pair lorazepam and lormetazepam is the clearest illustration in this Order that each molecule is listed on its own name. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Lorazepam in Bahamas, full detail →

LSD

Legal status: Controlled, and named in the Act rather than in the Order. Section 11(1)(m) of the Dangerous Drugs Act, Chapter 228, applies Part IV to «lysergic acid diethylamide and any compound declared by the Minister by Order to be a compound related to lysergic acid diethylamide». Searched case insensitively across the three held instruments: the phrase «lysergic acid diethylamide» appears twice in the Act and the words lysergide and LSD appear zero times in the operative 1994 Order, whose Psychotropic Schedule I runs from «BROLAMFETAMINE» to «TMA» with no lysergamide entry at all. Lysergide and LSD appear only in the 2024 draft Order, which is not law. So the UK derived convention of writing lysergide is absent here and the Bahamian printed form is the full chemical name.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: The compound limb of section 11(1)(m) is not self executing: a related compound reaches Part IV only once the Minister has declared it by Order, and no such Order was read. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

LSD in Bahamas, full detail →

MDA

Legal status: Controlled, under the international non proprietary name rather than the initialism. The 1994 Application Order prints «TENAMFETAMINE» against the other name «MDA» and the chemical name «alpha-methyl-3,4-(methylenedioxy)phenethylamine» in Substances in Schedule I of the Psychotropic Convention list. A search for tenamfetamine returns one hit in the 1994 Order and none in the Act. Two adjacent entries were read and distinguished: «N-ethyl MDA» and «N-hydroxy MDA» are separate named substances, not spellings of this one.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: Anyone searching these instruments for MDA by that initialism alone will land on the trivial name column; the operative name in the left hand column is tenamfetamine. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

MDA in Bahamas, full detail →

MDMA

Legal status: Controlled. The 1994 Application Order prints «MDMA» as an other non proprietary or trivial name against the chemical name «(+-)-N,alpha-dimethyl-3,4-(methylene-dioxy)phenethylamine» in Substances in Schedule I of the Psychotropic Convention list. The international non proprietary name column is blank for that row in the printed table, which is how the Order sets out a substance that has no international non proprietary name. The nearest entries either side are «ETICYCLIDINE» and «mescaline».
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27. Schedule I of the psychotropic list is the strictest of the four and no medical use is recognised for it in these instruments.
Documentation: The related compounds «N-ethyl MDA» and «N-hydroxy MDA» are separate entries in the same Schedule, each carrying its own 1990 inclusion footnote. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

MDMA in Bahamas, full detail →

MDPV

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for MDPV and for methylenedioxypyrovalerone: zero hits in the Act and zero in the operative 1994 Order. Both strings occur only in the 2024 draft Order. The nearest entry read and rejected is «PYROVALERONE», chemical name «4-methyl-2-(1-pyrrolidinyl)valerophenone» in Substances in Schedule IV of the Psychotropic Convention list. That is the same pyrrolidinyl valerophenone skeleton without the methylenedioxy ring, so this substance is a ring substituted relative of a listed entry and, absent any analogue clause in these schedules, is outside the Order.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

MDPV in Bahamas, full detail →

Memantine

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for memantine and for adamantane: zero hits in every one, including the 2024 draft Order. There is no nearest entry to reject. No adamantane derivative appears anywhere in Chapter 228 or the 1994 Order, and the fact that it shares a receptor target with the listed arylcyclohexylamines is not a listing route under an instrument that controls by name.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Memantine in Bahamas, full detail →

Mephedrone (4-MMC)

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for mephedrone: zero hits in the Act and zero in the operative 1994 Order. It occurs once, only in the 2024 draft Order. The nearest entry read and rejected is «METHCATHINONE», other names «ephedrone» and «methylcathinone», in Substances in Schedule I of the Psychotropic Convention list. This substance is that molecule with a methyl group on the aromatic ring. The Order names cathinone, methcathinone and cathine individually and provides no rule that reaches a ring substituted member of the family.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Mephedrone (4-MMC) in Bahamas, full detail →

Mescaline

Legal status: Controlled. The 1994 Application Order prints «mescaline», in lower case, as an other non proprietary or trivial name against the chemical name «3,4,5-trimethoxyphenethylamine» in Substances in Schedule I of the Psychotropic Convention list. The international non proprietary name column is blank for that row. Counted case insensitively: mescaline once in the 1994 Order and zero times in the Act. The adjacent entry «TMA», chemical name «(+-)-3,4,5-trimethoxy-alpha-methylphenethylamine», is the alpha methyl homologue and a different substance.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: The entry names the molecule and not any plant that contains it. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Mescaline in Bahamas, full detail →

Methadone

Legal status: Controlled by the Order rather than by the Act. The 1994 Application Order prints «Methadone (6-dimethylamino-4,4-diphenyl-3-heptanone)» and, separately, «Methadone intermediate (4-cyano-2-dimethylamino-4,4-diphenylbutane)» in the List of Drugs Included in Schedule I. The Act's single hit on a case insensitive search for methadone is not methadone at all: it is «normethadone» at section 11(1)(l), a different substance. Related entries in the same Order list include «Noracymethadol», «Alphacetylmethadol» and «Betacetylmethadol».
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27. No opioid substitution programme is provided for in Chapter 228 or in the 1994 Order.
Documentation: The intermediate is a separate entry, so possession of the precursor is charged on its own name rather than by analogy. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Methadone in Bahamas, full detail →

Methamphetamine

Legal status: Controlled. The 1994 Application Order prints the international non proprietary name «METAMFETAMINE» against the other name «methamphetamine» and the chemical name «(+)-(S)-N, alpha-dimethylphenethylamine» in Substances in Schedule II of the Psychotropic Convention list, and prints «METAMFETAMINE RACEMATE» immediately below it for the racemic form. Counted case insensitively: methamphetamine three times and metamfetamine twice in the 1994 Order, zero of either in the Act, whose section 11(1)(j) amphetamines wording does not on its face reach the N methylated compound.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: The separate racemate entry means the enantiomeric composition does not open a gap. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Methamphetamine in Bahamas, full detail →

Methaqualone (Quaaludes)

Legal status: Controlled. The 1994 Application Order prints «METHAQUALONE» with the chemical name «2-methyl-3-o-tolyl-4(3H)-quinazolinone» in Substances in Schedule II of the Psychotropic Convention list, and prints «MECLOQUALONE», chemical name «3-(o-chlorophenyl)-2-methyl-4(3H)-quinazolinone», in the same Schedule as a separate substance. Counted: methaqualone once in the 1994 Order and zero times in the Act.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: Two quinazolinones are named individually and nothing in the Order controls the class. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Methaqualone (Quaaludes) in Bahamas, full detail →

Methylone

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for methylone and for methylenedioxymethcathinone: zero hits in the Act and zero in the operative 1994 Order. Methylone occurs once, only in the 2024 draft Order. Two nearest entries were read and rejected: «METHCATHINONE» in Substances in Schedule I of the Psychotropic Convention list, which lacks the methylenedioxy ring, and «MDMA» in the same Schedule, which has the ring but is an amphetamine and not a cathinone because it lacks the ketone. This substance combines features of both and matches neither entry.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Methylone in Bahamas, full detail →

Methylphenidate

Legal status: Controlled. The 1994 Application Order prints «METHYLPHENIDATE» with the chemical name «Methyl alpha-phenyl-2-piperidineacetate» in Substances in Schedule II of the Psychotropic Convention list, between «METHAQUALONE» and «PHENCYCLIDINE». Counted: methylphenidate once in the 1994 Order and zero times in the Act. No brand name for it appears in either instrument.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27. A visitor holding a lawful foreign prescription is not a qualified person within section 24 and is not covered by it.
Documentation: It is a psychotropic Schedule II entry, the same tier as amphetamine, not the milder Schedule IV where most of the sedatives sit. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Methylphenidate in Bahamas, full detail →

Mitragynine

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for mitragynine and for the corynanthe alkaloid names: zero hits in every one, including the 2024 draft Order. There is no nearest entry to reject. The Order's only indole alkaloid entries are the simple tryptamines and this is a corynanthe type alkaloid with a substituted indole and a fused quinolizidine system, which nothing in either instrument reaches.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Mitragynine in Bahamas, full detail →

Modafinil

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for modafinil, for adrafinil and for the benzhydrylsulfinyl chemical name: zero hits in every one, including the 2024 draft Order. The nearest entries read and rejected are the non amphetamine stimulants the Order does name, «PEMOLINE», «MAZINDOL», «MESOCARB» and «PIPRADOL», all in Substances in Schedule IV of the Psychotropic Convention list. None of them shares this substance's sulfinyl acetamide structure.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Modafinil in Bahamas, full detail →

Morphine

Legal status: Controlled. Section 11(1)(c) of the Dangerous Drugs Act, Chapter 228, applies Part IV to «morphine and its salts», section 11(1)(e) to any preparation containing not less than one fifth per cent of morphine, and section 11(1)(g) to «morphine-N-oxide (commonly known as genomorphine), the morphine-N-oxide derivatives, and any other pentavalent nitrogen morphine derivatives». Section 11(2)(c) directs that the percentage in the case of morphine is calculated as anhydrous morphine. The word morphine occurs twenty nine times in the Act and twenty five times in the 1994 Order, the latter almost entirely inside derivative names such as «Morphine methobromide» and «Normorphine (demethylmorphine)» rather than as a standalone entry.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed. Section 22(8)(c) substitutes life imprisonment for the section 22 maxima where the quantity charged exceeds twenty grams of opium, morphine or its salts including diacetylmorphine.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: Section 12(1) separately forbids trading in any product obtained from the phenanthrene alkaloids of opium that was not in medical or scientific use on 13 August 1975. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Morphine in Bahamas, full detail →

MXE

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for MXE and for methoxetamine: zero hits in the Act and zero in the operative 1994 Order. Both strings occur only in the 2024 draft Order. The nearest entries read and rejected are «ETICYCLIDINE» and «TENOCYCLIDINE» in Substances in Schedule I of the Psychotropic Convention list, both N ethyl or thienyl arylcyclohexylamines. This substance is a methoxylated arylcyclohexanone, and the compound it is derived from, ketamine, is itself absent from the operative Order.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

MXE in Bahamas, full detail →

Nicotine

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for nicotine: zero hits in every one, including the 2024 draft Order. The nearest strings are the nicotinyl esters of opioids, «Nicomorphine (3,6-dinicotinylmorphine)», «Nicocodine (6-nicotinylcodeine)» and «Nicodicodine (6-nicotinyldihydrocodeine)» in the narcotic Schedules I and II of the 1994 Order. Those are listed for their morphinan half, and nicotinic acid is not nicotine. Tobacco and nicotine products are regulated outside Chapter 228 by law that was not read for this cell.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Nicotine in Bahamas, full detail →

Nimetazepam

Legal status: Controlled. The 1994 Application Order prints «NIMETAZEPAM» with the chemical name «1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one» in Substances in Schedule IV of the Psychotropic Convention list, immediately above «NITRAZEPAM», of which it is the N methyl analogue and from which it is a separate entry. Counted: nimetazepam once in the 1994 Order and zero times in the Act.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: The Bahamian instruments attach no special severity to this drug, in contrast to the jurisdictions that single it out. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Nimetazepam in Bahamas, full detail →

Nitrous Oxide

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for nitrous, for laughing gas and for dinitrogen: zero hits in every one, including the 2024 draft Order. There is no nearest entry to reject. No inhaled gas of any kind is named in Chapter 228 or in the 1994 Order, and no general anaesthetic appears in either.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Nitrous Oxide in Bahamas, full detail →

Opium

Legal status: Controlled, under three separate heads. Section 6 applies Part II to «raw opium», defined in section 2 as the spontaneously coagulated juice obtained from the capsules of the papaver somniferum. Part III deals with «prepared opium», meaning opium prepared for smoking including dross, and section 8 makes possessing it, smoking it, keeping pipes or utensils for it, or permitting premises to be used for it, offences in their own right. Section 11(1)(a) applies Part IV to «medicinal opium». The word opium appears thirty one times in the Act and ten times in the 1994 Order, where it survives as a concentration rule and in the Schedule III formula «Pulvis ipecacuanhae et opii compositus» at ten per cent opium in powder.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed. Section 22(8)(c) substitutes life imprisonment for the section 22 maxima where the quantity charged exceeds twenty grams of opium, morphine or its salts including diacetylmorphine. The Part III offences in section 8 are additional and do not require any quantity to be proved.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: Cultivation of «the opium poppy (Papaver somniferum)» is charged under section 29(1)(e). The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Opium in Bahamas, full detail →

Oxycodone

Legal status: Controlled, under a chemical name that a search for oxycodone will not find. Section 11(1)(g) of the Dangerous Drugs Act, Chapter 228, applies Part IV to «dihydrohydroxycodeinone», which is oxycodone, together with «dihydrocodeinone», «dihydromorphinone», «acetyldihydrocodeinone, (commonly known as ascedicone)» and «dihydromorphine», «their esters and the salts of any of these substances». Measured: the word oxycodone occurs zero times in the Act and zero times in the operative 1994 Order, whose nearest entry is «Oxymorphone (14-hydroxydihydromorphinone)», a different substance. The word oxycodone appears only in the 2024 draft Order, which is not law.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: Section 11(1)(i) extends Part IV to any preparation containing any proportion of a section 11(1)(g) substance, which takes combination tablets. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Oxycodone in Bahamas, full detail →

PCP

Legal status: Controlled. The 1994 Application Order prints «PHENCYCLIDINE» against the other name «PCP» and the chemical name «1-(1-phenylcyclohexyl)piperidine» in Substances in Schedule II of the Psychotropic Convention list. Three further arylcyclohexylamines are named in Schedule I of that list: «ETICYCLIDINE», other name PCE; «ROLICYCLIDINE», other names PHP and PCPY; and «TENOCYCLIDINE», other name TCP. Counted: phencyclidine once and PCP twice in the 1994 Order, zero of either in the Act.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: The four named arylcyclohexylamines are a closed list in these schedules and no generic clause extends them, which is why ketamine and methoxetamine are outside the Order. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

PCP in Bahamas, full detail →

Peyote

Legal status: Controlled through its alkaloid and not by its own name. Searched case insensitively across all three held instruments: peyote returns zero hits, and Lophophora williamsii returns zero hits. What the 1994 Application Order does print is «mescaline», chemical name «3,4,5-trimethoxyphenethylamine», in Substances in Schedule I of the Psychotropic Convention list, and mescaline is the cactus's principal alkaloid. So the cactus is reached as a preparation containing a named substance rather than as a listed botanical, which is the opposite of how the Act handles cannabis and coca, where the plant itself is named.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: Where the Bahamian drafters wanted a plant controlled as a plant they said so, in section 6 and section 29(1)(e); no cactus is named anywhere. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Peyote in Bahamas, full detail →

Phenibut

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for phenibut and for aminomethylphenylbutyric: zero hits in every one, including the 2024 draft Order, which does name the related gabapentinoids. There is no nearest entry to reject in the operative instruments, since no gamma aminobutyric acid derivative of any kind is named in either. The listed sedatives are barbiturates, benzodiazepines and a handful of individually named hypnotics such as «GLUTETHIMIDE», «ETHCHLORVYNOL» and «METHYPRYLON».
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Phenibut in Bahamas, full detail →

Poppers

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for poppers, for nitrite, for amyl and for isobutyl: zero hits in every one. This is a commercial label rather than a single substance, so the search was run on the alkyl nitrites it usually denotes as well as on the label itself, and both returned nothing. There is no nearest entry to reject. Because no alkyl nitrite at all is named, the absence holds whichever nitrite a given bottle contains, which is not true of the other mixture rows in this set.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Poppers in Bahamas, full detail →

Pregabalin

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for pregabalin: zero hits in the Act and zero in the operative 1994 Order. It occurs once, only in the 2024 draft Order, where it is printed with the chemical name for the S enantiomer beside a gabapentin entry. There is no nearest entry to reject, because no gabapentinoid is named in either operative instrument. This is one of the substances whose Bahamian status would change if the 2024 draft were made, and it has not been.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Pregabalin in Bahamas, full detail →

Psilocybin

Legal status: Controlled, and so is its active metabolite. The 1994 Application Order prints «PSILOCYBINE» with the chemical name «3-[2-(dimethylamino)ethyl]indol-4-yl dihydrogen phosphate», and separately «psilocine, psilotsin» with the chemical name «3-[2-(dimethylamino)ethyl]indol-4-ol», both in Substances in Schedule I of the Psychotropic Convention list. The spelling carries a terminal e. Neither mushroom nor Psilocybe appears anywhere in either instrument, so as with peyote the fungus is reached as a preparation containing the named substance.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: Two entries rather than one means that a preparation in which the phosphate has hydrolysed to psilocin is still squarely within the list. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Psilocybin in Bahamas, full detail →

Quetiapine

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for quetiapine and for dibenzothiazepine: zero hits in every one, including the 2024 draft Order. There is no nearest entry to reject. No antipsychotic is named anywhere in Chapter 228 or the 1994 Order; the nearest thing structurally is the thienodiazepine «CLOTIAZEPAM», which is a sedative of a different class listed in Substances in Schedule IV of the Psychotropic Convention list.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Quetiapine in Bahamas, full detail →

Salvia divinorum

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for salvia, for divinorum and for salvinorin: zero hits in every one, including the 2024 draft Order. There is no nearest entry to reject. The plant is not named, its diterpene is not named, and no terpenoid of any kind appears in either instrument, whose hallucinogen entries are all phenethylamines, tryptamines or arylcyclohexylamines.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Salvia divinorum in Bahamas, full detail →

Scopolamine (Devil's Breath)

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for scopolamine, for hyoscine and for the tropane names atropine and hyoscyamine. Atropine returns hits in the 1994 Order but not as an entry: it appears in Schedule III paragraphs 5 and 6 as «a quantity of atropine sulfate» required to be compounded with difenoxin and with diphenoxylate. Scopolamine and hyoscine return zero hits everywhere. So the nearest string read and rejected is that atropine compounding requirement, which regulates a preparation of a listed opioid rather than controlling the tropane alkaloid itself. No tropane is a listed substance in either instrument.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Scopolamine (Devil's Breath) in Bahamas, full detail →

Synthetic Cannabinoids (K2 / Spice)

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for synthetic cannabinoid, for cannabimimetic, for JWH and for the common core names: zero hits in the Act and zero in the operative 1994 Order. JWH occurs twice, only in the 2024 draft Order. This is an open chemical class rather than one molecule, so the search was run on the class terms and on the named series prefixes as well. The nearest entries read and rejected are the six tetrahydrocannabinol isomers in Substances in Schedule I of the Psychotropic Convention list and «delta-9-tetrahydrocannabinol» in Schedule II. All seven are dibenzopyrans and none of the indole or indazole derived compounds this class denotes shares that skeleton, so no listed entry reaches them.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Synthetic Cannabinoids (K2 / Spice) in Bahamas, full detail →

Tobacco

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for tobacco, for nicotiana and for cigarette: zero hits in every one, including the 2024 draft Order. There is no nearest entry to reject. Tobacco is not a dangerous drug under Chapter 228 and is dealt with by tobacco control and excise law that was not read for this cell.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Tobacco in Bahamas, full detail →

Tramadol

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for tramadol: zero hits in the Act and zero in the operative 1994 Order. It occurs once, only in the 2024 draft Order. There is no nearest entry to reject among the opioids the Order lists, which are all morphinans, pethidine type piperidines, methadone type open chain compounds or fentanyl type anilidopiperidines. This substance is an aminomethyl cyclohexanol and matches none of those families. It has never been scheduled under the 1961 Convention, which is why an Order that tracks the Convention schedules does not carry it.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Tramadol in Bahamas, full detail →

Xanax (Alprazolam)

Legal status: Controlled. The 1994 Application Order prints «ALPRAZOLAM» with the chemical name «8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-alpha][1,4]benzodiazepine» in Substances in Schedule IV of the Psychotropic Convention list, immediately after «ALLOBARBITAL». Counted: alprazolam once in the 1994 Order and zero times in the Act. The related triazolobenzodiazepines «ESTAZOLAM» and «TRIAZOLAM» are separately named in the same Schedule.
Consequences if caught: Possession without proper authority is an offence under section 29(6) of the Dangerous Drugs Act, Chapter 228, and section 29(2) fixes the penalty: on conviction on information a fine of 125,000 dollars or ten years imprisonment or both; on summary conviction a fine of 50,000 dollars or a term of imprisonment within the range of five to seven years or both. Conviction carries forfeiture to the Crown of all real or personal property in respect of which the offence was committed. Possession with intent to supply is a separate offence under section 22(1), punishable on information by a fine of 500,000 dollars or thirty years imprisonment or both, and summarily by four to seven years with a fine of 250,000 dollars, rising to six to seven years where the offence occurs within one mile of a school. Supply to a child or young person raises the information ceiling to 750,000 dollars or forty years. Section 22(3) presumes an intent to supply where a person is found with two or more packets of dangerous drugs. Section 33A forbids remission of any sentence below the term imposed.
If prescribed / medical: Section 24(1) authorises a qualified person to be in possession of and to supply a dangerous drug so far as necessary for the practice of his profession, and section 2 defines a qualified person as a registered medical practitioner, a registered dentist, a licensed veterinary surgeon, a licensed pharmacist, the public analyst, or a person granted special permission by the Minister. Section 24(2) requires the drug to be kept in a locked receptacle. Section 10(1) permits rules controlling manufacture, sale, possession and supply; no such rules were read for this cell. Import or export by anyone other than a qualified person is an offence under section 9, and needs an authorisation under Part V and permission under section 27.
Documentation: Psychotropic Schedule IV is the lowest of the four tiers, but Chapter 228 attaches the same Part IV offences and penalties to every drug the Order reaches, with no graduation by tier. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Xanax (Alprazolam) in Bahamas, full detail →

Xylazine

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for xylazine and for thiazine: zero hits in every one, including the 2024 draft Order. There is no nearest entry to reject. No veterinary sedative is named in either instrument, and the only place veterinary practice appears in Chapter 228 is the section 2 definition of a qualified person, which includes a licensed veterinary surgeon.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Xylazine in Bahamas, full detail →

Zolpidem

Legal status: Not listed in the Schedule to the Dangerous Drugs Act (Application) Order, 1994 (S.I. 77 of 1994) as those schedules stand after S.I. 50 of 1996, and not named in section 6 or section 11(1) of the Dangerous Drugs Act, Chapter 228. Searched case insensitively across all three held instruments for zolpidem and for imidazopyridine: zero hits in the Act and zero in the operative 1994 Order. Zolpidem occurs once, only in the 2024 draft Order. The nearest entries read and rejected are the non benzodiazepine hypnotics the Order does name, «GLUTETHIMIDE», «ETHCHLORVYNOL», «ETHINAMATE», «METHYPRYLON» and «MEPROBAMATE», all in Substances in Schedule IV of the Psychotropic Convention list. None is an imidazopyridine. This substance was added to the Psychotropic Convention schedules in 2001, after the 1994 Order and after its 1996 amendment.
Consequences if caught: No offence under Chapter 228 attaches to a substance that neither the Act nor the Application Order reaches, because every offence in the Act is framed around a drug to which the Act or a Part of it applies. One offence is still capable of applying: section 29(1)(f) with section 29(10) makes it an offence to solicit a person for the purpose of selling a dangerous drug, or to obtain money by representing that a substance is a dangerous drug when it is not.
If prescribed / medical: Chapter 228 does not reach it, so no authority under section 24 of that Act is needed to hold it. Chapter 228 is not the only law that can apply. The Pharmacy Act, the medicines law and the food and excise law of The Bahamas were not read for this cell and may regulate manufacture, sale or import independently of the drugs Act.
Documentation: A traveller carrying it into The Bahamas is not carrying a drug to which Chapter 228 applies on the reading above, but should expect the question to be settled at the border by the substance rather than by the brand name on the packet. The schedule placement stated here is not printed in the quotation column of the dossier read for this cell; it was read directly from the instrument text. No Ministerial Order later than S.I. 50 of 1996 was read for this cell, so a later addition by Order under section 6, section 11(3) or section 12(3) of the Act is not excluded. The Dangerous Drugs (Application) Order, 2024 was read and is not relied on: it carries no Statutory Instrument number, no signature and a blank execution block reading Made this day of 2024, and the Bahamas legislation portal serves it from its Bills directory rather than its subsidiary legislation directory.

Dangerous Drugs Act, Chapter 228, Statute Law of The Bahamas, LRO 1/2017 · laws.bahamas.gov.bs · Dangerous Drugs Act (Application) Order, 1994, S.I. 77 of 1994 as amended by S.I. 50 of 1996 · laws.bahamas.gov.bs · Dangerous Drugs (Application) Order, 2024, an unexecuted draft that the Bahamas legislation portal serves from its Bills directory, read but not relied on · laws.bahamas.gov.bs · Updated October 2, 2026

Zolpidem in Bahamas, full detail →

Substance	What we found
1P-LSD	Not confirmed. Searched case insensitively across all three held instruments for 1P-LSD and for the propionyl...
Cannabinol	Not confirmed. Searched case insensitively across all three held instruments for cannabinol as a standalone word....
CBD	Not confirmed. Searched case insensitively across all three held instruments for cannabidiol and for CBD: zero hits...
HHC	Not confirmed. Searched case insensitively across all three held instruments for HHC and for hexahydrocannabinol...
LSA (Morning Glory)	Not confirmed. Searched case insensitively across all three held instruments for ergine, for lysergic acid amide...
Pink Cocaine / Tusi	Not confirmed. The name does not identify a substance. Searched case insensitively across all three held...
THC-P	Not confirmed. Searched case insensitively across all three held instruments for THCP, for THC-P and for...

Legal status in Bahamas

Confirmed legal status

2-FDCK

25I-NBOMe

2C-B

2C-E

2C-I

2C-T-7

3-MMC

4-AcO-DMT

4-HO-MET

5-MeO-DMT (Bufo / Toad)

6-APB

7-Hydroxymitragynine (7-OH)

Adderall

Alcohol

Amanita muscaria

Amphetamine

Amyl Nitrite

Ayahuasca

Barbiturates

Benzodiazepines

Buprenorphine

Caffeine

Cannabis / THC

Cathinone

Clonazepam

Cocaine

Codeine

Crack Cocaine

Delta-8-THC

Diazepam

DMT

DOM

DXM

Ephedrine

Etizolam

Fentanyl

Gabapentin

GBL

GHB

Heroin

Hydrocodone

Ketamine

Khat

Kratom

Lorazepam

LSD

MDA

MDMA

MDPV

Memantine

Mephedrone (4-MMC)

Mescaline

Methadone

Methamphetamine

Methaqualone (Quaaludes)

Methylone

Methylphenidate

Mitragynine

Modafinil

Morphine

MXE

Nicotine

Nimetazepam

Nitrous Oxide

Opium

Oxycodone

PCP

Peyote

Phenibut

Poppers

Pregabalin

Psilocybin

Quetiapine

Salvia divinorum

Scopolamine (Devil's Breath)

Synthetic Cannabinoids (K2 / Spice)

Tobacco

Tramadol